Pacific Edge Limited
NZX:PEB.NZ
Overview | Financials
Company Name | Pacific Edge Limited |
Symbol | PEB.NZ |
Currency | NZD |
Price | 0.102 |
Market Cap | 82,657,229 |
Dividend Yield | 0% |
52-week-range | 0.05 - 0.56 |
Industry | Diagnostics & Research |
Sector | Healthcare |
CEO | Dr. Peter Meintjes |
Website | https://www.pacificedgedx.com |
An error occurred while fetching data.
About Pacific Edge Limited
Pacific Edge Limited, a cancer diagnostic company, researches, develops, and commercializes diagnostic and prognostic tools for the early detection and management of cancers in New Zealand, the United States, Australia, and Singapore. It operates in two segments, Commercial and Research. The company offers Cxbladder, a genomic urine tests for the
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD